Online ISSN: 1947-6027
www.genesandcancer.com
About Genes & Cancer
Our mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.

LEARN MORE ABOUT GENES & CANCER

Genes & Cancer | VCP/p97 as a Therapeutic Target in KRAS-Mutant Pancreatic Cancer

News

March 24, 2023
PRESS RELEASE: On March 10, 2023, a new research paper was published in Genes & Cancer, entitled, “VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer.” continue reading »

Genes & Cancer | Severe Herpesvirus Infection Beats Adult T-cell Leukemia/Lymphoma

News

February 24, 2023
PRESS RELEASE: On January 19, 2023, Genes & Cancer published a new editorial, entitled, “Severe herpesvirus infection beats adult T-cell leukemia/lymphoma.” continue reading »

Genes & Cancer | CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens

Genes & Cancer

February 10, 2023
PRESS RELEASE: A new review was published in Genes & Cancer on February 1, 2023, entitled, “CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens.” continue reading »

Genes & Cancer | Leveraging Allogeneic Dendritic Cells for Neoantigen Cancer Vaccines

News

February 3, 2023
PRESS RELEASE: On January 30, 2023, a new research perspective was published in Genes & Cancer, entitled, “Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.” continue reading »

Genes & Cancer | Slit2 signaling stimulates Ewing sarcoma growth

Genes & Cancer

January 13, 2023
PRESS RELEASE: On December 14, 2022, a new research paper was published in Genes & Cancer, entitled, “Slit2 signaling stimulates Ewing sarcoma growth.” continue reading »